Dr. Yung’s lifelong passion for medicine and health stems from his fascination with the intersection of advanced molecular and stem cell biology and traditional healing, such as Traditional Chinese Medicine. His academic journey began at the University of California, Berkeley, where he earned dual A.B. degrees in Molecular & Cell Biology and Cognitive Sciences, deepening his understanding of the molecular mechanisms of the brain and consciousness. Further research at Stanford University’s School of Medicine explored brain tumor biology, leading to a PhD in Biomedical Sciences from UC San Diego, where his discoveries in lipid signaling and single-cell genomics shaped foundational insights into brain development and disease.

Following his doctoral studies, Dr. Yung’s postdoctoral work at Scripps Research and Sanford Burnham Prebys Medical Discovery Institute focused on the molecular and environmental influences on perinatal brain development and disorders like hydrocephalus. His transition into applied biotechnology at The Scintillon Research Institute marked a new phase—bridging bench research with therapeutic innovation. There, he led pioneering projects in stem cell therapies, bioactive compounds, and high-throughput disease diagnostics, including the use of AI and nanoantibodies. As a Group Leader at Allele Biotechnology and co-founder of Allele Cypert Technology, Dr. Yung continues to contribute to advancing induced pluripotent stem cell applications for treating conditions such as macular degeneration, spinal cord injury, and heart disease.

In 2024, Dr. Yung founded Pomelo Biosciences to translate decades of scientific discovery into accessible, peptide-based wellness innovations. Through its product lines PEP+ STRYDE and PEP+ BEAM, the company merges biotechnology and consumer health to enhance cellular repair and longevity. Beyond his entrepreneurial and research endeavors, Dr. Yung remains committed to mentorship and service—guiding young scientists through Scintillon’s internship programs and serving as Chair of the Hydrocephalus Association’s Scientific Advisory Board, where he helps drive research and advocacy efforts to improve patient outcomes and find a cure for hydrocephalus.